Moreover, we found that the activation of the EP4 receptor negatively regulates the IREB2-MFRN2 axis by increasing FBXL5 expression, ultimately reducing mitochondrial iron deposition in AECII and potentially offering a treatment strategy for pulmonary fibrosis. The gene discussed is FBXL5; the disease is pulmonary fibrosis.